Asia-Pacific Cancer Monoclonal Antibodies Market Trends, Size, Competitive Analysis and Forecast 2020-2026

Asia-Pacific cancer monoclonal antibodies market is estimated to grow at a CAGR of 11.2% during the forecast period. Increasing awareness regarding cancer is one of the pivotal factors accelerating market growth. Biopharmaceutical firms have reported the launch of public awareness campaigns for cancer. For instance, in May 2016 Roche launched a public awareness campaign known as ‘Run for Her’. This campaign aims to deliver successfully crucial messages regarding the need for breast cancer screening in women frequently. Early diagnosis and consistent treatment can lead to improving disease outcomes and quality of life of breast cancer patients. 

To Request a Sample of our Report on Asia-Pacific Cancer Monoclonal Antibodies Market:  https://www.omrglobal.com/request-sample/asia-pacific-cancer-monoclonal-antibodies-market

The company organized this campaign in collaboration with the China Cancer Rehabilitation Society, to increase public awareness regarding breast cancer. This initiative can support improving awareness, testing, and therapeutics of breast cancer in China, which in turn, will accelerate the demand for monoclonal antibody treatment that serves as one of the established therapeutic strategies for both solid tumors and hematologic malignancies. It is a type of immunotherapy that stimulates the immune system of cancer patients and works to recognize and attack cancer cells. 

 Scope of the Asia-Pacific Cancer Monoclonal Antibodies Market

·        Market Coverage

·        Market number available for 2019-2026

·        Base year- 2019

·        Forecast period- 2020-2026

·        Segment Covered- By Type and Application

·        Regions Covered- China, India, Japan, and Rest of Asia-Pacific

·        Competitive Landscape- Biocon Ltd., Amgen Inc., F. Hoffman La-Roche AG, Pfizer Inc., and Mylan N.V.

Recent Strategic Initiatives in the Asia-Pacific Cancer Monoclonal Antibodies Market

·        In July 2020, Ahmedabad-based Cadila Pharmaceuticals Ltd. declared the introduction of biosimilar Rituximab in India. It is indicated for the treatment of rheumatoid arthritis and blood cancer launched within the brand name Ritucad. It is used to treat Non-Hodgkin’s lymphoma (a type of blood-related cancer). According to the company, over 28,000 new cases of Lymphoma are reported each year in India. This launch will increase the accessibility of cancer treatment in the country. 

·        In October 2019, Amgen declared collaboration with BeiGene that will further widen Amgen's plans to enhance its oncology presence in China. Under the agreement, BeiGene will commercialize BLINCYTO (blinatumomab), XGEVA (denosumab), and KYPROLIS (carfilzomib) in China. Additionally, this acquisition will also support Amgen for the commercialization of its non-oncology product portfolio in China. 

 (Get 15% Discount on Buying this Report)

A full Report of Asia-Pacific Cancer Monoclonal Antibodies Market is Available at:  https://www.omrglobal.com/industry-reports/asia-pacific-cancer-monoclonal-antibodies-market

Key questions addressed by the report

·        What is the market growth rate?

·        Which segment dominates the market in the base year?

·        Which segment will project the fastest growth in the market?

·        How COVID-19 impacted the market?

Ø  Recovery Timeline

Ø  Deviation from the pre-COVID forecast

Ø  Most affected segment

·        Who is the leader in the market?

·        How players are addressing challenges to sustain growth?

·        Where is the investment opportunity?

Asia-Pacific Cancer Monoclonal Antibodies Market-Segmentation

By Type

·        Naked 

·        Conjugated

·        Others (Bispecific)

By Application

·        Breast Cancer

·        Liver Cancer

·        Blood Cancer

·        Brain Cancer

·        Colorectal Cancer

·        Others

Asia-Pacific Cancer Monoclonal Antibodies Market– Segment by Country

·                  India

·                  China

·                  Japan

·                  South Korea

Rest of APAC

Company Profiles

·        Amgen Inc.

·        Anhui Anke Biotechnology (Group) Co., Ltd.

·        Biocon Ltd.

·        Chugai Pharmaceutical Co., Ltd.

·        Daiichi Sankyo Company, Ltd.

·        Dr. Reddy's Laboratories, Inc.

·        Genor BioPharma Co., Ltd.

·        Lupin Ltd.

·        Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

·        Takeda Pharmaceutical Co., Ltd.

·        Zhejiang Hisun Pharmaceutical Co., Ltd.

Reasons to Buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/asia-pacific-cancer-monoclonal-antibodies-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more